Besides, the mutation of many SLC25s made high-risk effects on the prognosis of ovarian serous cystadenocarcinoma such as SLC25A8, SLC25A24, SLC25A25, and SLC25A31. This evidence concerns the gene SLC25A25 and ovarian serous cystadenocarcinoma.